Search results
Ben Michael Goldacre OBE (born 20 May 1974) is a British physician, academic and science writer. He is the first Bennett Professor of Evidence-Based Medicine and director of the Bennett Institute for Applied Data Science at the University of Oxford.
Bennett Professor of Evidence-Based Medicine Director of Bennett Institute for Applied Data Science. Ben is a doctor, academic, writer, and broadcaster. He trained in medicine at Oxford and UCL, in psychiatry at the Maudsley, and in epidemiology at LSHTM.
Director of Bennett Institute for Applied Data Science. Ben is a doctor, academic, writer, and broadcaster. He trained in medicine at Oxford and UCL, in psychiatry at the Maudsley, and in epidemiology at LSHTM. His academic and policy work is in informatics, epidemiology and evidence based medicine, where he works on various problems including ...
Every day there are news reports of new health advice, but how can you know if they're right? Doctor and epidemiologist Ben Goldacre shows us, at high speed, the ways evidence can be distorted, from the blindingly obvious nutrition claims to the very subtle tricks of the pharmaceutical industry.
Jul 20, 2016 · Ben Goldacre. Debunker. Home: alltrials.net Website: Bad Science Book: Bad Science. TED Speaker. Personal profile. Ben Goldacre unpicks dodgy scientific claims made by scaremongering journalists, dubious government reports, pharmaceutical corporations, PR companies and quacks. Why you should listen.
People also ask
Who is Ben Goldacre and what does he do?
Who is Dr Goldacre?
Who is Michael Goldacre?
Who is goldacres?
RSM In Conversation Live with Professor Ben Goldacre. Royal Society of Medicine. 13.2K subscribers. Subscribed. 51. 3.2K views 1 year ago. Recorded on Wednesday 27 April 2022 as part of The...
- 60 min
- 3.4K
- Royal Society of Medicine
Mar 6, 2019 · Ben Goldacre, 44, is a senior clinical research fellow at the Nuffield Department of Primary Care Health Sciences in Oxford. He is a doctor, academic, and science writer whose book Bad Science (2008) propelled him to international fame, selling 500 000 copies in the UK alone.
